Clinical trials in Hodgkin lymphoma


The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for Hodgkin lymphoma patients.

 If you would like to know how to access our trials please click here


Trial Name




Click for more information (external page)




A phase 1 study testing a new drug, ADCT-301

Suitable for patients with lymphoma which has come back after previous treatment




*Please note, we update this page fortnightly

With special thanks to the following: